(Q34184393)

31 July 2017

1 reference

title

Cell-free nucleic acids as biomarkers in cancer patients (English)

1 reference

31 July 2017

0 references

0 references

3

Klaus Pantel

1 reference

31 July 2017

1

Heidi Schwarzenbach

1 reference

31 July 2017

Dave S B Hoon

2

1 reference

PubMed ID

21562580

31 July 2017

language of work or name

English

0 references

publication date

12 May 2011

1 reference

31 July 2017

Nature Reviews Cancer

1 reference

31 July 2017

11

1 reference

31 July 2017

426-437

1 reference

31 July 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3066

31 July 2017

0 references

cites work

Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia

1 reference

Microsatellite alterations in serum DNA of head and neck cancer patients

31 March 2020

1 reference

Medicine. Keeping tabs on tumor DNA.

31 March 2020

1 reference

Circulating nucleic acids in plasma and serum: recent developments

31 March 2020

1 reference

The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells

31 March 2020

1 reference

The origin and mechanism of circulating DNA

31 March 2020

1 reference

Circulating nucleic acids in plasma and serum. Recent developments

31 March 2020

1 reference

Detection and quantification of mutations in the plasma of patients with colorectal tumors

31 March 2020

1 reference

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

31 March 2020

1 reference

Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.

31 March 2020

1 reference

CIRCULATING DNA AS A POSSIBLE FACTOR IN ONCOGENESIS.

31 March 2020

1 reference

Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients

31 March 2020

1 reference

Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate Disease

31 March 2020

1 reference

Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker

31 March 2020

1 reference

Role of cell-free plasma DNA as a diagnostic marker for prostate cancer.

31 March 2020

1 reference

Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer

31 March 2020

1 reference

Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.

31 March 2020

1 reference

Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.

31 March 2020

1 reference

Amount of DNA in plasma and cancer risk: A prospective study

31 March 2020

1 reference

Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer.

31 March 2020

1 reference

Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer

31 March 2020

1 reference

Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker

31 March 2020

1 reference

Quantitative analysis of circulating mitochondrial DNA in plasma

31 March 2020

1 reference

Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.

31 March 2020

1 reference

Prediction of breast tumor progression by integrity of free circulating DNA in serum.

31 March 2020

1 reference

Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats

31 March 2020

1 reference

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

31 March 2020

1 reference

Multimarker circulating DNA assay for assessing blood of prostate cancer patients

31 March 2020

1 reference

Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer

31 March 2020

1 reference

Role of active cell death (apoptosis) in multi-stage carcinogenesis

31 March 2020

1 reference

Clinical biomarkers in oncology: focus on colorectal cancer

31 March 2020

1 reference

Targeting RAS signalling pathways in cancer therapy

31 March 2020

1 reference

The first 30 years of p53: growing ever more complex

31 March 2020

1 reference

K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance

31 March 2020

1 reference

A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.

31 March 2020

1 reference

Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced non-small cell lung cancer.

31 March 2020

1 reference

Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy

31 March 2020

1 reference

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

31 March 2020

1 reference

Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors

31 March 2020

1 reference

EGFR antagonists in cancer treatment

31 March 2020

1 reference

EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib

31 March 2020

1 reference

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

31 March 2020

1 reference

Active Alu retrotransposons in the human genome

31 March 2020

1 reference

Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer

31 March 2020

1 reference

Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients

31 March 2020

1 reference

Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer

31 March 2020

1 reference

Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions

31 March 2020

1 reference

Genomic DNA methylation: the mark and its mediators

31 March 2020

1 reference

PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment

31 March 2020

1 reference

CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer

31 March 2020

1 reference

Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients

31 March 2020

1 reference

Histone deacetylase inhibitors in cancer therapy

31 March 2020

1 reference

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

31 March 2020

1 reference

Cell-surface-bound nucleic acids: Free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients

31 March 2020

1 reference

Apoptosis and nucleosomes

31 March 2020

1 reference

31 March 2020

Biomarkers of apoptosis

1 reference

Nucleosomes in serum of patients with benign and malignant diseases

31 March 2020

1 reference

31 March 2020

1 reference

Clinical relevance of circulating nucleosomes in cancer.

31 March 2020

1 reference

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

31 March 2020

1 reference

Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico

31 March 2020

1 reference

Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomas.

31 March 2020

1 reference

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

31 March 2020

1 reference

Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma

31 March 2020

1 reference

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

31 March 2020

1 reference

Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging.

31 March 2020

1 reference

Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells

31 March 2020

1 reference

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

31 March 2020

1 reference

Flow cytometric analysis of circulating microparticles in plasma

31 March 2020

1 reference

Shedding microvesicles: artefacts no more

31 March 2020

1 reference

Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.

31 March 2020

1 reference

Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer.

31 March 2020

1 reference

Free circulating mRNA in plasma from breast cancer patients and clinical outcome

31 March 2020

1 reference

Reduced plasma RNA integrity in nasopharyngeal carcinoma patients.

31 March 2020

1 reference

Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer

31 March 2020

1 reference

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

31 March 2020

1 reference

Circulating microRNAs as stable blood-based markers for cancer detection

31 March 2020

1 reference

Suitable reference genes for relative quantification of miRNA expression in prostate cancer

31 March 2020

1 reference

A novel and universal method for microRNA RT-qPCR data normalization

31 March 2020

1 reference

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

31 March 2020

1 reference

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

31 March 2020

1 reference

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

31 March 2020

1 reference

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

31 March 2020

1 reference

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

31 March 2020

1 reference

MicroRNA expression profiles classify human cancers

31 March 2020

1 reference

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.

31 March 2020

1 reference

Circulating tumour cells in cancer patients: challenges and perspectives

31 March 2020

1 reference

Detection, clinical relevance and specific biological properties of disseminating tumour cells

31 March 2020

1 reference

Microsatellite analysis of serum DNA in patients with head and neck cancer

31 March 2020

1 reference

Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients

31 March 2020

1 reference

Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression

31 March 2020

1 reference

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

31 March 2020

1 reference

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

31 March 2020

1 reference

Circulating mutant DNA to assess tumor dynamics

31 March 2020

1 reference

Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

31 March 2020

1 reference

The methyl-CpG binding domain and the evolving role of DNA methylation in animals

31 March 2020

1 reference

Chemical regulation of epigenetic modifications: opportunities for new cancer therapy.

31 March 2020

1 reference

Linking DNA methylation and histone modification: patterns and paradigms

31 March 2020

1 reference

Causes and consequences of microRNA dysregulation in cancer

31 March 2020

1 reference

MicroRNAs: target recognition and regulatory functions

31 March 2020

1 reference

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity.

31 March 2020

1 reference

Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer

31 March 2020

1 reference

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients

31 March 2020

1 reference

Extracellular DNA in breast cancer: Cell-surface-bound, tumor-derived extracellular DNA in blood of patients with breast cancer and nonmalignant tumors.

31 March 2020

1 reference

CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients.

31 March 2020

1 reference

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

31 March 2020

1 reference

Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation

31 March 2020

1 reference

Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer

31 March 2020

1 reference

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

31 March 2020

1 reference

Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients

31 March 2020

1 reference

DNA methylation in serum and tumors of cervical cancer patients

31 March 2020

1 reference

Human papillomavirus DNA in plasma of patients with cervical cancer

31 March 2020

1 reference

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

31 March 2020

1 reference

Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer.

31 March 2020

1 reference

Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases

31 March 2020

1 reference

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

31 March 2020

1 reference

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

31 March 2020

1 reference

Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer

31 March 2020

1 reference

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions

31 March 2020

1 reference

Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma

31 March 2020

1 reference

Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients

31 March 2020

1 reference

The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma

31 March 2020

1 reference

Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa

31 March 2020

1 reference

249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.

31 March 2020

1 reference

Quantitative analysis of plasma HBV DNA for early evaluation of the response to transcatheter arterial embolization for HBV-related hepatocellular carcinoma

31 March 2020

1 reference

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

31 March 2020

1 reference

Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer

31 March 2020

1 reference

Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients

31 March 2020

1 reference

Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications.

31 March 2020

1 reference

Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer.

31 March 2020

1 reference

14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.

31 March 2020

1 reference

TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma

31 March 2020

1 reference

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

31 March 2020

1 reference

Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.

31 March 2020

1 reference

Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients.

31 March 2020

1 reference

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.

31 March 2020

1 reference

Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients

31 March 2020

1 reference

Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome

31 March 2020

1 reference

Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma

31 March 2020

1 reference

Differential methylation profile of ovarian cancer in tissues and plasma

31 March 2020

1 reference

Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool

31 March 2020

1 reference

Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer

31 March 2020

1 reference

Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.

31 March 2020

1 reference

Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis

31 March 2020

1 reference

Methylation profile of circulating plasma DNA in patients with pancreatic cancer

31 March 2020

1 reference

Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy

31 March 2020

1 reference

Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients

31 March 2020

1 reference

DNA-based detection of prostate cancer in blood, urine, and ejaculates.

31 March 2020

1 reference

Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer

31 March 2020

1 reference

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.

31 March 2020

1 reference

Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators

31 March 2020

1 reference

Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.

31 March 2020

1 reference

31 March 2020

Global cancer statistics

1 reference

Soluble normal and mutated DNA sequences from single-copy genes in human blood

31 March 2020

1 reference

12 December 2020

1 reference

12 December 2020

Molecular detection of genetic alterations in the serum of colorectal cancer patients

1 reference

12 December 2020

Methylation of endogenous human retroelements in health and disease.

1 reference

12 December 2020

Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients

1 reference

12 December 2020

Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer

1 reference

12 December 2020

Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients

1 reference

12 December 2020

Circulating nucleic acids (CNAs) and cancer--a survey

1 reference

12 December 2020

Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis

1 reference

12 December 2020

Detection of Stage I nasopharyngeal carcinoma by serologic screening and clinical examination

1 reference

12 December 2020

Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients

1 reference

12 December 2020

Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.

1 reference

12 December 2020

DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

1 reference

12 December 2020

MicroRNAs as Novel Biomarkers for Breast Cancer

1 reference

12 December 2020

Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma

1 reference

12 December 2020

Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival

1 reference

12 December 2020

p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer

1 reference

12 December 2020

Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.

1 reference

12 December 2020

Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue

1 reference

12 December 2020

Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer.

1 reference

12 December 2020

Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.

1 reference

12 December 2020

Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients

1 reference

12 December 2020

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements

1 reference

12 December 2020

Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative RT-PCR.

1 reference

12 December 2020

Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA.

1 reference

12 December 2020

Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.

1 reference

12 December 2020

Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.

1 reference

12 December 2020

https://api.fatcat.wiki/v0/release/cea3ql4qsbfdrkhvfngb76rb6i

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1049890524

0 references

Fatcat ID

release_cea3ql4qsbfdrkhvfngb76rb6i

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cea3ql4qsbfdrkhvfngb76rb6i

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/cea3ql4qsbfdrkhvfngb76rb6i

30 July 2022